Influence of patient's relationship status and HPV history on physicians' decisions to recommend HPV vaccination

Vaccine

Volumn 29, Issue 3, 2011, Pages 378-381

  Zimet, Gregory D ^a   Stupiansky, Nathan W ^a   Weiss, Thomas W ^b   Rosenthal, Susan L ^c   Good, Margaret B ^d   Vichnin, Michelle D ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d i3 Innovus   (United States)

Author keywords

Attitude of health personnel; Marital status; Papillomavirus vaccines

Indexed keywords

WART VIRUS VACCINE;

ADULT; ANAMNESIS; ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC TEST ACCURACY STUDY; FAMILY MEDICINE; FEMALE; GENERAL PRACTICE; GYNECOLOGY; HEALTH SURVEY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; MONOGAMY; OBSTETRICS; PAPANICOLAOU TEST; PHYSICIAN; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SEXUALITY; UNITED STATES; VACCINATION; WART VIRUS;

ADOLESCENT; ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; CHILD; FEMALE; HUMANS; MALE; MARRIAGE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PHYSICIANS; QUESTIONNAIRES; RISK FACTORS; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 78650521986     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.11.027     Document Type: Article

References (30)

1. Weinstock H., Berman S., Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004, 36(1):6-10.
2. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al. Prevalence of HPV infection among females in the United States. JAMA 2007, 297(8):813-819.
3. Food and Drug Administration Approval letter-human papillomavirus quadrivalent (types 6, 11, 16, 18) vaccine, recombinant 2006, June 8 [accessed 10/18/2010]. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm111283.htm.
4. Food and Drug Administration Approval letter-Cervarix 2009, October 16 [accessed 10/18/2010]. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186959.htm.
5. Centers for Disease Control and Prevention Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee for Immunization Practices (ACIP). MMWR 2007, 56(RR-2):1-24.
6. Centers for Disease Control and Prevention FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR 2010, 59:626-629.
7. Centers for Disease Control and Prevention National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2009. MMWR 2010, 59:1018-1023.
8. Conroy K., Rosenthal S.L., Zimet G.D., Jin Y., Bernstein D.I., Glynn S., Kahn J.A. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Women's Health 2009, 18(10):1679-1686.
9. Grant D., Kravitz-Wirtz N., Breen N., Tiro J.A., Tsui J. One in four California adolescent girls have had human papillomavirus vaccination. Policy Brief UCLA Cent Health Policy Res 2009, (PB2009-3):1-6.
10. Jain N., Euler G.L., Shefer A., Lu P., Yankey D., Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med 2009, 48(5):426-431.
11. Zimet G.D., Mays R.M., Winston Y., Kee R., Dickes J., Su L. Acceptability of human papillomavirus immunization. J Womens Health Gend Based Med 2000, 9(1):47-50.
12. Brewer N.T., Fazekas K.I. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007, 45(2-3):107-114.
13. Jones M., Cook R. Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Health 2008, 57(1):23-32.
14. Lenehan J.G., Leonard K.C., Nandra S., Isaacs C.R., Mathew A., Fisher W.A. Women's knowledge, attitudes, and intentions concerning human papillomavirus vaccination: findings of a waiting room survey of obstetrics-gynaecology outpatients. J Obstet Gynaecol Can 2008, 30(6):489-499.
15. Rosenthal S.L., Weiss T.W., Zimet G.D., Ma L., Good M.B., Vichnin M.D. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine 2010, 10.1016/j.vaccine.2009.12.063.
16. Caskey R., Lindau S.T., Alexander G.C. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health 2009, 45(5):453-462.
17. Cook J.V., Dickinson H.O., Eccles M.P. Response rates in postal surveys of healthcare professionals between 1996 and 2005: an observational study. BMC Health Serv Res 2009, 9:160.
18. Kahn J.A., Zimet G.D., Bernstein D.I., Riedesel J.M., Lan D., Huang B., et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health 2005, 37(6):502-510.
19. Kahn J.A., Rosenthal S.L., Tissot A.M., Bernstein D.I., Wetzel C., Zimet G.D. Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr 2007, 7(5):367-373.
20. Ishibashi K.L., Koopmans J., Curlin F.A., Alexander K.A., Ross L.F. Pediatricians are more supportive of the human papillomavirus vaccine than the general public. South Med J 2008, 101(12):1216-1221.
21. Daley M.F., Liddon N., Crane L.A., Beaty B.L., Barrow J., Babbel C., et al. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics 2006, 118:2280-2289.
22. Raley J.C., Followwill K.A., Zimet G.D., Ault K.A. Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol 2004, 12(3-4):127-133.
23. Riedesel J.M., Rosenthal S.L., Zimet G.D., Bernstein D.I., Huang B., Lan D., et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol 2005, 18(6):391-398.
24. Jensen M.E., Hartenbach E., McElroy J.A., Faerber A., Havighurst T., Kim K.M., et al. Measuring the attitudes of health care professionals in Dane County toward adolescent immunization with HPV vaccine. Wisc Med J 2009, 108:203-205.
25. Tariq S., Bhakta S., Grimes A., Stevens A. Attitudes of Arkansas' primary care physicians toward the HPV vaccine. J Ark Med Soc 2009, 106:113-117.
26. Schnatz P.F., Humphrey K., O'Sullivan D.M. Assessment of the perceptions and administration of the human papillomavirus vaccine. J Low Genit Tract Dis 2010, 14(2):103-107.
27. Daley M.F., Crane L.A., Markowitz L.E., Black S.R., Beaty B.L., Barrow J., et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010, 126:425-433.
28. Zimet G.D., Weiss T.W., Rosenthal S.L., Good M.B., Vichnin M.D. Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women. BMC Women's Health 2010, 10:27.
29. Kahn J.A., Lan D., Kahn R.S. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol 2007, 110(1):87-95.
30. Bosch F.X., Burchell A.N., Schiffman M., Giuliano A.R., de Sanjose S., Bruni L., et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008, 26(Suppl. 10):K1-K16.